Global support for a quality solution

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide signs significant commercial agreement

19 Dec 2022 - Baar, 19 December 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced the signing of a […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide provides market update

2 Dec 2022 - Baar, 2 December 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today provided a market update. […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry